Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer

被引：0
作者：
Di Huang
Fan Zhang
Haitao Tao
Sujie Zhang
Junxun Ma
Jinliang Wang
Zhefeng Liu
Pengfei Cui
Shixue Chen
Ziwei Huang
Zhaozhen Wu
Lei Zhao
Yi Hu
机构：
[1] Nankai University,School of Medicine
[2] Chinese People’s Liberation Army General Hospital,Department of Medical Oncology
[3] Chinese PLA General Hospital,Department of Graduate Administration
来源：
Targeted Oncology | 2020年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：93 / 100
页数：7
相关论文
共 50 条
[21]   PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient [J].
Yu, Zhuo ;
Zhang, Peiqing ;
Gu, Weikuan ;
Jiang, Xicheng .
TRANSLATIONAL CANCER RESEARCH, 2019, 8 (08) :2941-2943
[22]   Efficacy and safety of the PD-1/PD-L1 in metastasic non-small cell lung cancer (NSCLC) [J].
Gonzalez-Velez, Abel ;
Pino-Villareal, Luis E. ;
Barrera-Barinas, Alexander ;
Castillo-Niuman, Andrea ;
Tolosa-Perez, Erica N. ;
Castelblanco, Diana, I ;
Pinzon-Florez, Carlos E. ;
Yomayusa, Nancy .
GACETA MEXICANA DE ONCOLOGIA, 2021, 20 (03) :111-123
[23]   Efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer patients with sensitive genes mutation [J].
Cui, H-J. ;
Zheng, S-Y. .
ANNALS OF ONCOLOGY, 2019, 30 :511-511
[24]   PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC) [J].
Krenbek, Dagmar ;
Weidinger, Barbara ;
Jarius, Christa ;
Holzer, Sophia ;
Fabican, Hannah ;
Mohn-Staudner, Andrea ;
Hochmair, Maximilian ;
Chott, Andreas ;
Setinekl, Ulrike .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S430-S430
[25]   PD-L1 expression: An emerging biomarker in non-small cell lung cancer [J].
Adam, Julien ;
Planchard, David ;
Marabelle, Aurelien ;
Soria, Jean-Charles ;
Scoazec, Jean-Yves ;
Lantuejoul, Sylvie .
ANNALES DE PATHOLOGIE, 2016, 36 (01) :94-102
[26]   PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small Cell Lung Cancer Patients with or without EGFR Mutation [J].
Siripoon, T. ;
Incharoen, P. ;
Trachu, N. ;
Munthum, D. ;
Kamprerasart, K. ;
Reungwetwattana, T. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) :S699-S700
[27]   PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes [J].
He, Yayi ;
Rozeboom, Leslie ;
Rivard, Christopher J. ;
Ellison, Kim ;
Dziadziuszko, Rafal ;
Yu, Hui ;
Zhou, Caicun ;
Hirsch, Fred R. .
MEDICAL SCIENCE MONITOR, 2017, 23 :1208-1216
[28]   Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer [J].
Schatz, Stefanie ;
Falk, Markus ;
Jori, Balazs ;
Ramdani, Hayat O. ;
Schmidt, Stefanie ;
Willing, Eva-Maria ;
Menon, Roopika ;
Groen, Harry J. M. ;
Diehl, Linda ;
Kroeger, Matthias ;
Wesseler, Claas ;
Griesinger, Frank ;
Hoffknecht, Petra ;
Tiemann, Markus ;
Heukamp, Lukas C. .
CANCERS, 2020, 12 (06) :1-14
[29]   The impact of genomic mutational status on PD-L1 expression and tumor mutation burden in non-small cell lung cancer [J].
Zhou, Qing ;
Gu, Weiguang ;
Fu, WenFan ;
Mai, Shijie ;
Lin, Daren ;
Zhang, Shiyue ;
Wang, Wenjing ;
Zhang, Peng .
CANCER RESEARCH, 2019, 79 (13)
[30]   Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non-Small Cell Lung Cancer [J].
Li, Jia-Xin ;
Huang, Ju-Min ;
Jiang, Ze-Bo ;
Li, Run-Ze ;
Sun, Ao ;
Leung, Elaine Lai-Han ;
Yan, Pei-Yu .
INTEGRATIVE CANCER THERAPIES, 2019, 18
12345